Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy.
about
Targeting Hsp90 in urothelial carcinomaBladder Sparing Approaches for Muscle-Invasive Bladder CancersManagement of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgeryBladder cancer in the elderly patient: challenges and solutionsElevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial CarcinomaAtezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladder.Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma.The impact of a solitary kidney on tolerability to gemcitabine plus cisplatin chemotherapy in urothelial carcinoma patients: a retrospective study.Systemic therapy in bladder cancerPhase II study of everolimus in metastatic urothelial cancer.CKD-EPI and cockcroft-gault equations identify similar candidates for neoadjuvant chemotherapy in muscle-invasive bladder cancerControversies in the treatment of invasive urothelial carcinoma: a case report and review of the literature.Metabolic complete response with vinflunine as second-line therapy in a kidney-transplanted patient with advanced urothelial carcinoma: a case report.Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer.Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)Urothelial carcinoma management in elderly or unfit patients.Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysisNeoadjuvant paradigm for accelerated drug development: an ideal model in bladder cancer.The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).Circulating Biomarkers in Bladder Cancer.Current management of muscle-invasive bladder cancer.Urothelial cancers: using biology to improve outcomes.Novel molecular targets for the therapy of urothelial carcinoma.Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy.Sunitinib malate in the treatment of urothelial cancer.Emerging drugs for urothelial carcinoma.Update in systemic therapy of urologic malignancies.Optimal treatment for metastatic bladder cancer.The role of genomics in the management of advanced bladder cancer.Docetaxel for the treatment of bladder cancer.New Model for Estimating Glomerular Filtration Rate in Patients With Cancer.Improving Systemic Chemotherapy for Bladder Cancer.Pharmacokinetic drug evaluation of atezolizumab for the treatment of locally advanced or metastatic urothelial carcinoma.The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.Trends in cancer of the urinary bladder and urinary tract in elderly in Denmark, 2008-2012.Late-onset distant metastatic upper urinary tract urothelial carcinoma mimicking lung adenocarcinomaPD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomyPerspectives in immunotherapy: meeting report from the "Immunotherapy Bridge", Napoli, November 30th 2016.
P2860
Q27023406-D9B155C5-9D5E-4E31-80F6-FBB40A237302Q28072814-0A7F4072-BC9F-448C-8C26-266FEBAC7559Q28074930-0B4FAD5F-BB91-4543-92E2-8CC3BBE8D6BEQ28082782-7C14C1BB-6CD4-44C8-98B7-C47647E6AA45Q28084715-F35D1FFA-7EB1-4E02-AD2A-6EC5C4D4B608Q30275266-1562EFC1-3053-493E-9A5D-FA9CBD6701E5Q33407440-52A7F964-AF24-453A-9078-BDDF281B89BCQ33411962-8317B7B5-D1EF-43F5-B480-3D5C35050875Q33440800-6D7278D2-AB67-404E-B529-BD17DBC24529Q33578564-61BDD00C-7D3C-42D9-8163-88C3125CF1B9Q33606604-D59966FA-67B9-4B3E-B7FD-1770FCA67DAEQ35145440-ABB5F43B-A44E-4522-9042-3697F87AC463Q35180823-392279BF-4985-4B05-BF6F-47C8329BF0D4Q36103157-DC0A8DEA-F9D4-4008-8CF1-5DF3D300DC40Q36615090-4938216E-5539-4040-B4C5-5283D8E6179CQ36627206-BD7C3B2C-95F4-484B-A30A-F1FDA39ACE56Q37030514-3A8E1C49-F2E2-4DD3-9DFB-4A162C92AAC0Q37045540-DB074705-E738-4493-B5A1-B7DE51ADAE6EQ37128756-F9FCED54-02CC-4539-B58B-C4E0770A8046Q37187791-121C565F-E0BA-4072-BB17-D8E4D4BA2375Q37475193-19AEB91A-BED4-4BA9-BFEA-7FCD92ECC441Q37530401-DFA3EEA4-2B1C-4621-B123-6B00F519A819Q37962658-5B4A50E1-0461-40A5-B21B-14CE53B7276DQ37965638-40AAD00A-AC77-4391-A8D2-E1763F8372A5Q38003195-904069D7-AAC7-43CF-B974-0DD26D03DCAEQ38077272-D74DCDAA-504D-46F6-86E6-B73BD816294FQ38159713-6B99A40B-68DC-4616-A92B-D0564FB21A6AQ38160271-148F7137-384E-4921-A464-272050D25E2EQ38176143-90761805-9137-4A13-BE06-B033886FB4D4Q38233326-33287A15-77C7-490F-A7B2-82BDA599EA1FQ38342992-57FD1C8B-A6A2-4BC5-8D60-0545DA589858Q38624895-196FD1EA-AA03-43EA-AAA2-29B0CAF22F43Q38689410-694E3979-447D-4807-BCB8-08F8E255811CQ38777610-725AB607-212B-4E8B-8258-520A19863BCFQ39064758-73861965-24FC-47AA-B34A-88319768C786Q39480721-F366089F-603B-4687-AD35-6503BF973F68Q40089617-05A2D301-B64A-4C7C-B444-E124EC8463C4Q41999802-53B4960B-0BC6-467F-AF4E-2CDC0AF139A8Q42366515-8121FEBC-5446-411F-B40A-F1F354F9A3A0Q42375254-16DB78CE-D478-4F78-BA94-0924B539FB9E
P2860
Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of patients with met ...... Cisplatin-based chemotherapy.
@en
Treatment of patients with met ...... Cisplatin-based chemotherapy.
@nl
type
label
Treatment of patients with met ...... Cisplatin-based chemotherapy.
@en
Treatment of patients with met ...... Cisplatin-based chemotherapy.
@nl
prefLabel
Treatment of patients with met ...... Cisplatin-based chemotherapy.
@en
Treatment of patients with met ...... Cisplatin-based chemotherapy.
@nl
P2093
P356
P1476
Treatment of patients with met ...... r Cisplatin-based chemotherapy
@en
P2093
Cora N Sternberg
Dean F Bajorin
Guru Sonpavde
Joaquim Bellmunt
Jonathan Rosenberg
Matthew D Galsky
Nicholas Vogelzang
Noah M Hahn
Robert Dreicer
Thomas Hutson
P304
P356
10.1200/JCO.2011.34.8433
P407
P577
2011-05-09T00:00:00Z